Does one model fit all mAbs? An evaluation of population pharmacokinetic models by Stefan P. H. van den Berg, Philine E. A. Adolfsen, Thomas P.C. Dorlo, Theo Rispens

Get full text

Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis by Stefan P. H. van denBerg, Alyssa A. Toorop, Femke Hooijberg, Gertjan Wolbink, Nivea M. F. Voelkner, Liza M. Y. Gelissen, Joep Killestein, Zoé L. E. vanKempen, Thomas P. C. Dorlo, Theo Rispens

Get full text

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. by Eltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, Raymond Omollo, Ahmed M Musa, Workagegnehu Hailu, Abuzaid A Abuzaid, Thomas P C Dorlo, Zewdu Hurissa, Sisay Yifru, William Haleke, Peter G Smith, Sally Ellis, Manica Balasegaram, Ahmed M EL-Hassan, Gerard J Schoone, Monique Wasunna, Robert Kimutai, Tansy Edwards, Asrat Hailu

Get full text